v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
Total revenues $ 34,518 $ 25,691 $ 68,254 $ 49,757
Operating expenses:        
Cost of revenue 0 (243) 0 (380)
Research and development (14,759) (26,710) (26,581) (48,231)
General and administrative (8,466) (15,518) (15,326) (31,237)
Fair value adjustments 0 69   69
Total operating expenses (23,225) (42,402) (41,907) (79,779)
Operating income (loss) 11,293 (16,711) 26,347 (30,022)
Other income (expense):        
Non-operating income (expense) 856 (12) 648 (276)
MiNK Therapeutics, Inc. equity method investment fair value adjustment 2,526 0 1,176 0
Gain on Zydus asset sale 0 0 40,379 0
Interest expense, net (15,242) (13,289) (29,911) (26,084)
Net income (loss) (567) (30,012) 38,639 (56,382)
Dividends on Series A-1 convertible preferred stock (54) (54) (109) (108)
Less: net loss attributable to non-controlling interest (17) (2,057) (37) (3,161)
Net income (loss) attributable to Agenus Inc. common stockholders $ (604) $ (28,009) $ 38,567 $ (53,329)
Per common share data:        
Basic $ (0.01) $ (1) $ 0.97 $ (2.03)
Diluted $ (0.01) $ (1) $ 0.96 $ (2.03)
Weighted average number of Agenus Inc. common shares outstanding:        
Basic 41,338 28,117 39,649 26,303
Diluted 41,338 28,117 40,123 26,303
Other comprehensive income (loss):        
Foreign currency translation loss $ (13) $ (36) $ (11) $ (106)
Other comprehensive loss (13) (36) (11) (106)
Comprehensive income (loss) (617) (28,045) 38,556 (53,435)
Research and Development Revenue [Member]        
Revenue:        
Total revenues 0 334 0 334
Pre-Commercial Product Revenue [Member]        
Revenue:        
Total revenues 6,372 0 10,963 0
Service Revenue [Member]        
Revenue:        
Total revenues 0 526 0 1,036
Non-Cash Royalty Revenue Related to the Sale of Future Royalties [Member]        
Revenue:        
Total revenues $ 28,146 $ 24,831 $ 57,291 $ 48,387